GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (CHIX:1SXPd) » Definitions » ROA %

Schott Pharma AG KGaA (CHIX:1SXPD) ROA % : 7.91% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Schott Pharma AG KGaA ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Schott Pharma AG KGaA's annualized Net Income for the quarter that ended in Dec. 2024 was €115.6 Mil. Schott Pharma AG KGaA's average Total Assets over the quarter that ended in Dec. 2024 was €1,461.0 Mil. Therefore, Schott Pharma AG KGaA's annualized ROA % for the quarter that ended in Dec. 2024 was 7.91%.

The historical rank and industry rank for Schott Pharma AG KGaA's ROA % or its related term are showing as below:

CHIX:1SXPd' s ROA % Range Over the Past 10 Years
Min: 9.69   Med: 12.95   Max: 15.08
Current: 9.69

During the past 5 years, Schott Pharma AG KGaA's highest ROA % was 15.08%. The lowest was 9.69%. And the median was 12.95%.

CHIX:1SXPd's ROA % is ranked better than
87.11% of 869 companies
in the Medical Devices & Instruments industry
Industry Median: -1.56 vs CHIX:1SXPd: 9.69

Schott Pharma AG KGaA ROA % Historical Data

The historical data trend for Schott Pharma AG KGaA's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA ROA % Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
ROA %
13.00 15.08 12.95 12.51 11.20

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.37 7.70 13.42 9.57 7.91

Competitive Comparison of Schott Pharma AG KGaA's ROA %

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Schott Pharma AG KGaA's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's ROA % distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's ROA % falls into.



Schott Pharma AG KGaA ROA % Calculation

Schott Pharma AG KGaA's annualized ROA % for the fiscal year that ended in Sep. 2024 is calculated as:

ROA %=Net Income (A: Sep. 2024 )/( (Total Assets (A: Sep. 2023 )+Total Assets (A: Sep. 2024 ))/ count )
=149.685/( (1231.828+1442.269)/ 2 )
=149.685/1337.0485
=11.20 %

Schott Pharma AG KGaA's annualized ROA % for the quarter that ended in Dec. 2024 is calculated as:

ROA %=Net Income (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=115.576/( (1442.269+1479.646)/ 2 )
=115.576/1460.9575
=7.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2024) net income data. ROA % is displayed in the 30-year financial page.


Schott Pharma AG KGaA  (CHIX:1SXPd) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2024 )
=Net Income/Total Assets
=115.576/1460.9575
=(Net Income / Revenue)*(Revenue / Total Assets)
=(115.576 / 919.364)*(919.364 / 1460.9575)
=Net Margin %*Asset Turnover
=12.57 %*0.6293
=7.91 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Schott Pharma AG KGaA ROA % Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Schott Pharma AG KGaA Business Description

Traded in Other Exchanges
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines